DHR Danaher Corporation

By Austen Hufford 

Science, health care and technology conglomerate Danaher Corp. on Tuesday posted revenue and profit increases in its fourth quarter.

In November, Danaher bought molecular-diagnostics company Cepheid Inc. for about $4 billion, in its first major acquisition since spinning off a large chunk of its business. In July, Danaher completed the spinoff of its test and measurement, industrial technologies, and petroleum platform segments into their own public company, Fortive Corp.

For the quarter ended Dec 31, the company posted a profit of $747 million, or $1.07 a share, up from $688.6 million, or 99 cents a share, a year earlier.

Excluding certain items, earnings on a per-share basis were $1.05.

Revenue climbed 6% to $4.58 billion.

Analysts had expected $4.53 billion in revenue and adjusted earnings per share of $1.03.

The company had core sales growth of 3.5% and deal-driven growth of 4%.

Shares in the company, inactive premarket, have risen 2.3% over the past three months.

Write to Austen Hufford at austen.hufford@wsj.com

(END) Dow Jones Newswires

January 31, 2017 06:52 ET (11:52 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.